Featured Research

from universities, journals, and other organizations

FAK inhibitor effectively blocked colon cancer cell growth and viability

Date:
October 28, 2010
Source:
American Association for Cancer Research
Summary:
Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice.

Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell viability, promoted detachment and apoptosis, and decreased tumor growth in mice. These findings were presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.

Related Articles


"We believe that these types of novel small molecule inhibitors may be the future direction for cancer therapy," said Melissa Heffler, M.D., a research associate at Roswell Park Cancer Institute in Buffalo, N.Y. "We are excited that Y15 showed efficacy in decreasing colon cancer cell growth. This is just the first step in pushing these molecules closer to clinical use."

Because more than 80 percent of colon cancers overexpress FAK, Heffler and colleagues investigated whether inhibiting FAK action would affect the growth of colon cancer cells in the laboratory. They first evaluated whether Y15 would decrease the growth of SW620, a highly aggressive colon cancer cell line, in vitro. They then administered the drug to mice to evaluate whether it would decrease tumor growth in vivo. According to Heffler, Y15 is unique because it blocks the site of Y397, which is not specifically targeted by other drugs.

In vitro results showed that Y15 decreased FAK expression and activation in a dose- and time-dependent manner. Compared with control, a 1 µM dose of Y15 inhibited cell viability. Cell detachment also decreased as dosage increased, with nearly 100 percent of cells detached at 50 µM of Y15.

In mice treated with Y15 after being injected with SW620 cells, tumor volume was significantly less after 19 days of treatment than that of mice treated with Y15A derivative or a negative control.

"Although we have shown the efficacy of this inhibitor in treating other types of cancers, like neuroblastoma and breast and pancreatic cancers, metastatic colon cancer can be especially difficult to treat," Heffler said. "Our inhibitor has worked on these cells, and early data have suggested that it might even work better than the standard colon cancer chemotherapy, 5-fluorouracil."

The researchers plan to further study Y15 in comparison to and in combination with 5-fluorouracil and plan to investigate its effect on the inhibition of metastases in vivo using a mouse model. They recently submitted untreated and treated cells to a microarray facility for gene analysis and hope to use those data to identify the detailed mechanism by which Y15 influences tumor growth.

"Our preclinical results are promising and will, hopefully, lead to further investigation of this FAK inhibitor in a clinical setting," Heffler said. "Ideally, we ultimately hope to provide novel therapies for clinicians to employ for the benefit of their patients fighting cancer."


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

American Association for Cancer Research. "FAK inhibitor effectively blocked colon cancer cell growth and viability." ScienceDaily. ScienceDaily, 28 October 2010. <www.sciencedaily.com/releases/2010/10/101028132259.htm>.
American Association for Cancer Research. (2010, October 28). FAK inhibitor effectively blocked colon cancer cell growth and viability. ScienceDaily. Retrieved March 28, 2015 from www.sciencedaily.com/releases/2010/10/101028132259.htm
American Association for Cancer Research. "FAK inhibitor effectively blocked colon cancer cell growth and viability." ScienceDaily. www.sciencedaily.com/releases/2010/10/101028132259.htm (accessed March 28, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, March 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com
What's Different About This Latest Ebola Vaccine

What's Different About This Latest Ebola Vaccine

Newsy (Mar. 26, 2015) — A whole virus Ebola vaccine has been shown to protect monkeys exposed to the virus. Here&apos;s what&apos;s different about this vaccine. Video provided by Newsy
Powered by NewsLook.com
HIV Outbreak Prompts Public Health Emergency In Indiana

HIV Outbreak Prompts Public Health Emergency In Indiana

Newsy (Mar. 26, 2015) — Indiana Gov. Mike Pence says he will bring additional state resources to help stop the epidemic. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins